Priyanka Sharma Selected Research

Adjuvant Chemotherapy

2/2024	Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
7/2023	Limb Salvage Strategy Amendment for a Better Future in the Era of Bone Cancer Therapy: A Cross-Sectional Study in North India.
3/2020	Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
1/2019	Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Priyanka Sharma Research Topics

Disease

76	Neoplasms (Cancer) 03/2024 - 12/2006
52	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2004
17	Triple Negative Breast Neoplasms 03/2024 - 09/2012
16	COVID-19 12/2024 - 03/2021
16	Infections 08/2023 - 01/2011
12	Virus Diseases (Viral Diseases) 01/2024 - 01/2012
9	Neoplasm Metastasis (Metastasis) 10/2023 - 07/2010
8	Typhoid Fever (Typhoid) 11/2023 - 01/2015
7	Pathologic Complete Response 03/2024 - 02/2017
7	Carcinogenesis 10/2019 - 01/2009
6	Inflammation (Inflammations) 03/2021 - 11/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 02/2019 - 01/2005
5	Obesity 01/2024 - 01/2021
5	Melanoma (Melanoma, Malignant) 01/2021 - 11/2010
5	Hypoxia (Hypoxemia) 01/2020 - 08/2014
4	Carcinoma (Carcinomatosis) 07/2023 - 01/2010
4	Type 2 Diabetes Mellitus (MODY) 02/2023 - 02/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2020
4	Adenoviridae Infections (Adenovirus Infections) 01/2022 - 01/2012
3	Fatigue 02/2024 - 01/2010
3	Genomic Instability 01/2024 - 07/2014
3	Pain (Aches) 01/2024 - 08/2012
3	Residual Neoplasm 11/2023 - 01/2022
3	Body Weight (Weight, Body) 10/2023 - 01/2022
3	Gliosis 06/2023 - 12/2018
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 02/2015
3	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2017
3	Leukemia 01/2022 - 10/2017
3	Squamous Cell Carcinoma of Head and Neck 10/2019 - 01/2018
3	Wounds and Injuries (Trauma) 12/2018 - 01/2014
3	Arthralgia (Joint Pain) 11/2017 - 01/2010
3	Papilloma (Papillomatosis) 01/2011 - 01/2009
3	Hyperplasia 10/2010 - 09/2004

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
17	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2007
15	Estrogen ReceptorsIBA 10/2023 - 11/2006
13	Hormones (Hormone)IBA 03/2024 - 09/2004
12	VaccinesIBA 12/2024 - 01/2018
9	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2010
7	Progesterone Receptors (Progesterone Receptor)IBA 10/2023 - 04/2012
7	EnzymesIBA 08/2022 - 01/2010
7	MicroRNAs (MicroRNA)IBA 11/2020 - 06/2013
6	AnthracyclinesIBA 03/2024 - 02/2017
6	LipidsIBA 01/2024 - 01/2010
6	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 07/2014
6	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2015
6	LigandsIBA 10/2023 - 01/2016
6	Protein Isoforms (Isoforms)IBA 12/2021 - 09/2012
5	ErbB Receptors (EGF Receptor)IBA 03/2024 - 01/2018
5	AntigensIBA 01/2024 - 10/2017
5	human ERBB2 proteinIBA 10/2023 - 01/2020
5	ZincIBA 08/2023 - 10/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2015
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2006
5	AntioxidantsIBA 01/2020 - 11/2010
5	OsteopontinIBA 08/2014 - 12/2006
5	HomocysteineIBA 05/2014 - 01/2005
4	Aromatase InhibitorsIBA 03/2024 - 01/2010
4	PhytochemicalsIBA 01/2024 - 02/2020
4	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2023 - 01/2019
4	Letrozole (Femara)FDA LinkGeneric 05/2023 - 01/2010
4	Phosphotransferases (Kinase)IBA 04/2023 - 12/2006
4	taxaneIBA 11/2022 - 02/2017
4	Estrogens (Estrogen)FDA Link 07/2022 - 01/2010
4	Messenger RNA (mRNA)IBA 01/2022 - 12/2015
4	ProteomeIBA 01/2021 - 12/2014
3	Peptides (Polypeptides)IBA 12/2023 - 01/2019
3	Docetaxel (Taxotere)FDA Link 11/2023 - 02/2017
3	pembrolizumabIBA 11/2023 - 11/2017
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2023 - 08/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 12/2019
3	Circulating Tumor DNAIBA 03/2023 - 01/2021
3	CalciumIBA 01/2023 - 03/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2020
3	PlatinumIBA 01/2023 - 01/2017
3	adenovirus receptorIBA 01/2022 - 04/2015
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2019
3	Phenobarbital (Luminal)FDA Link 03/2020 - 10/2019
3	FluoroquinolonesIBA 01/2020 - 01/2015
3	Cholic AcidIBA 09/2019 - 01/2019
3	CytokinesIBA 08/2014 - 09/2011
3	ChemokinesIBA 08/2014 - 12/2006
3	Croton OilIBA 09/2011 - 01/2009
3	AcetoneIBA 09/2011 - 01/2009
2	Fulvestrant (Faslodex)FDA Link 03/2024 - 01/2022
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024 - 01/2021
2	mRNA VaccinesIBA 03/2024 - 01/2022
2	COVID-19 VaccinesIBA 03/2024 - 01/2022
2	olaparibIBA 02/2024 - 01/2019
2	Pit and Fissure Sealants (Dental Sealants)IBA 01/2024 - 03/2023

Therapy/Procedure

42	Therapeutics 03/2024 - 01/2010
22	Drug Therapy (Chemotherapy) 03/2024 - 09/2011
10	Neoadjuvant Therapy 03/2024 - 02/2015
4	Adjuvant Chemotherapy 02/2024 - 01/2019
4	Radiotherapy 02/2024 - 01/2018
3	Immunotherapy 12/2023 - 10/2017
3	Ayurvedic Medicine (Siddha Medicine) 02/2023 - 03/2021
3	Chemoprevention 01/2009 - 11/2006